ArticleCureus2025
A Rare Case of Polyserositis With Elevated Serum Cancer Antigen (CA)-125 in Systemic Lupus Erythematosus: A Case Report of Pseudo-Pseudo Meigs Syndrome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudo-pseudo Meigs syndrome (PPMS) is a rare condition characterized by pleural effusion, ascites, and elevated cancer antigen (CA)-125 levels in the setting of systemic lupus erythematosus (SLE) without evidence of ovarian tumors. We report a case of a 24-year-old woman with a known history of SLE for three years. Her symptoms were well-controlled with prednisolone and hydroxychloroquine. She presented with a history of shortness of breath, diffuse abdominal pain, and abdominal distension. Initial diagnostic workup revealed ascites, elevated CA-125 levels, and pleural effusion, without evidence of malignancy. A series of confirmatory tests excluded other differential diagnoses, leading to a diagnosis of PPMS. The patient was treated initially with furosemide without improvement. After confirming the diagnosis, methylprednisolone and oral prednisone were then administered with a favorable prognosis. This case contributes to the literature by highlighting PPMS as an important differential diagnosis to be considered in patients with SLE. Early recognition is crucial to minimize the need for unnecessary invasive procedures. The goal is to initiate the appropriate management as early as possible to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.